Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated:  1/18/2013
Clinical Research Facility
mi
from
Chattanooga, TN
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated: 1/18/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated:  1/18/2013
Clinical Research Facility
mi
from
Dallas, TX
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated: 1/18/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated:  1/18/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated: 1/18/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated:  1/18/2013
Clinical Research Facility
mi
from
Norfolk, VA
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated: 1/18/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated:  1/18/2013
Clinical Research Facility
mi
from
Seattle, WA
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status: Enrolling
Updated: 1/18/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma
A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma
Status: Enrolling
Updated:  1/22/2013
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma
A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma
Status: Enrolling
Updated: 1/22/2013
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 1 Safety Study of ALRN-5281 in Healthy Subjects
A Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety and Tolerability of ALRN-5281 Administered by Subcutaneous Injection in Healthy Adult Volunteers
Status: Enrolling
Updated:  1/24/2013
Vince and Associates Clinical Research, LLC
mi
from
Overland Park, KA
Phase 1 Safety Study of ALRN-5281 in Healthy Subjects
A Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety and Tolerability of ALRN-5281 Administered by Subcutaneous Injection in Healthy Adult Volunteers
Status: Enrolling
Updated: 1/24/2013
Vince and Associates Clinical Research, LLC
mi
from
Overland Park, KA
Click here to add this to my saved trials
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated:  2/5/2013
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated: 2/5/2013
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Click here to add this to my saved trials
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated:  2/5/2013
Hospital for Special Surgery
mi
from
New York, NY
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated: 2/5/2013
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity
Phase 2 Study of the Assessment of the Insulin Sensitizing Activity of Fenretinide in Subjects With Insulin Resistance With BMI >30Kg/m2, and Liver Inflammation Related to Non-alcoholic Fatty Liver
Status: Enrolling
Updated:  2/11/2013
University of California at San Diego Hospitals
mi
from
San Diego, CA
A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity
Phase 2 Study of the Assessment of the Insulin Sensitizing Activity of Fenretinide in Subjects With Insulin Resistance With BMI >30Kg/m2, and Liver Inflammation Related to Non-alcoholic Fatty Liver
Status: Enrolling
Updated: 2/11/2013
University of California at San Diego Hospitals
mi
from
San Diego, CA
Click here to add this to my saved trials
Radius Loading in Primary Hyperparathyroidism
Effect of Mechanical Loading on Radius Bone Density and Microarchitecture in Primary Hyperparathyroidism
Status: Enrolling
Updated:  2/12/2013
Columbia University Medical Center
mi
from
New York, NY
Radius Loading in Primary Hyperparathyroidism
Effect of Mechanical Loading on Radius Bone Density and Microarchitecture in Primary Hyperparathyroidism
Status: Enrolling
Updated: 2/12/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
Optical Probe In Thyroid Cancer
Status: Enrolling
Updated:  2/13/2013
Boston Med Ctr
mi
from
Boston, MA
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
Optical Probe In Thyroid Cancer
Status: Enrolling
Updated: 2/13/2013
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
Development and Evaluation of Enhanced Digital Health Coaching Program for Depressive Symptoms to Support Collaborative Depression Treatment in Primary Care: The RESPECT-D-E (Enhanced) Trial
Status: Enrolling
Updated:  2/14/2013
Family Medicine Clinics, Cheshire Medical Center (DH-Keene)
mi
from
Keene, NH
Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
Development and Evaluation of Enhanced Digital Health Coaching Program for Depressive Symptoms to Support Collaborative Depression Treatment in Primary Care: The RESPECT-D-E (Enhanced) Trial
Status: Enrolling
Updated: 2/14/2013
Family Medicine Clinics, Cheshire Medical Center (DH-Keene)
mi
from
Keene, NH
Click here to add this to my saved trials
Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome
Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome
Status: Enrolling
Updated:  2/25/2013
East Tennessee State Univ
mi
from
Johnson City, TN
Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome
Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome
Status: Enrolling
Updated: 2/25/2013
East Tennessee State Univ
mi
from
Johnson City, TN
Click here to add this to my saved trials
Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
Dutasteride in Men Receiving Testosterone Therapy: Impact on Serum PSA, Testosterone, DHT Levels and Prostate Volume: "Implications for Prostate Safety"
Status: Enrolling
Updated:  2/25/2013
Men's Health Boston
mi
from
Boston, MA
Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
Dutasteride in Men Receiving Testosterone Therapy: Impact on Serum PSA, Testosterone, DHT Levels and Prostate Volume: "Implications for Prostate Safety"
Status: Enrolling
Updated: 2/25/2013
Men's Health Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
Dutasteride in Men Receiving Testosterone Therapy: Impact on Serum PSA, Testosterone, DHT Levels and Prostate Volume: "Implications for Prostate Safety"
Status: Enrolling
Updated:  2/25/2013
Miriam Hospital
mi
from
Providence, RI
Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
Dutasteride in Men Receiving Testosterone Therapy: Impact on Serum PSA, Testosterone, DHT Levels and Prostate Volume: "Implications for Prostate Safety"
Status: Enrolling
Updated: 2/25/2013
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Insulin Resistance in Smokers Undergoing Smoking Cessation
Insulin Resistance in Smokers Undergoing Smoking Cessation
Status: Enrolling
Updated:  3/25/2013
Charles Drew University of Medicine and Science
mi
from
Los Angeles, CA
Insulin Resistance in Smokers Undergoing Smoking Cessation
Insulin Resistance in Smokers Undergoing Smoking Cessation
Status: Enrolling
Updated: 3/25/2013
Charles Drew University of Medicine and Science
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Birmingham, AL
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Louisville, KY
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Henderson, NV
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Newark, NJ
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
New York, NY
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Charleston, SC
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Dallas, TX
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated:  3/28/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Phase III Study to Evaluated Morning Testosterone Normalization in Overweight Men Less Than 60 Years of Age With Secondary Hypogonadism
A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration
Status: Enrolling
Updated: 3/28/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Physiological Response of Cortisol to Cardiac Catheterization
Physiological Response of Cortisol to Cardiac Catheterization
Status: Enrolling
Updated:  3/28/2013
Creighton University
mi
from
Omaha, NE
Physiological Response of Cortisol to Cardiac Catheterization
Physiological Response of Cortisol to Cardiac Catheterization
Status: Enrolling
Updated: 3/28/2013
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Effect of Aged Garlic Extract on Atherosclerosis
Effect of Aged Garlic Extract on Atherosclerosis
Status: Enrolling
Updated:  4/15/2013
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Effect of Aged Garlic Extract on Atherosclerosis
Effect of Aged Garlic Extract on Atherosclerosis
Status: Enrolling
Updated: 4/15/2013
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Metabolomic Analysis of Hepatic Insulin Resistance
Metabolomic Analysis of Hepatic Insulin Resistance
Status: Enrolling
Updated:  4/15/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Metabolomic Analysis of Hepatic Insulin Resistance
Metabolomic Analysis of Hepatic Insulin Resistance
Status: Enrolling
Updated: 4/15/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza
Changes in Appetite, Weight, Body Composition, Endothelial Function and Biomarkers in Patients With the Cardiometabolic Syndrome: Comparison of a Combination of Berberine, Lipoic Acid, and Picrorhiza Versus Placebo (The "BANGALORE" Study)
Status: Enrolling
Updated:  4/17/2013
Atlanta Vascular Research Foundation
mi
from
Atlanta, GA
The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza
Changes in Appetite, Weight, Body Composition, Endothelial Function and Biomarkers in Patients With the Cardiometabolic Syndrome: Comparison of a Combination of Berberine, Lipoic Acid, and Picrorhiza Versus Placebo (The "BANGALORE" Study)
Status: Enrolling
Updated: 4/17/2013
Atlanta Vascular Research Foundation
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
A Prospective Safety, Tolerance, Pharmacodynamics and Pharmacokinetics Study of Sobetirome in Male Subjects Diagnosed With X-linked Adrenoleukodystrophy (X-ALD)
Status: Enrolling
Updated:  4/17/2013
Oregon Health and Science University
mi
from
Portland, OR
Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
A Prospective Safety, Tolerance, Pharmacodynamics and Pharmacokinetics Study of Sobetirome in Male Subjects Diagnosed With X-linked Adrenoleukodystrophy (X-ALD)
Status: Enrolling
Updated: 4/17/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
A Phase One, Open Label, Single Arm Study to Demonstrate the Safety of Antria Cell Preparation Process During Facial Fat Grafting Assisted With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
Status: Enrolling
Updated:  4/20/2013
Delmont Surgery Center
mi
from
Greensburg, PA
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
A Phase One, Open Label, Single Arm Study to Demonstrate the Safety of Antria Cell Preparation Process During Facial Fat Grafting Assisted With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
Status: Enrolling
Updated: 4/20/2013
Delmont Surgery Center
mi
from
Greensburg, PA
Click here to add this to my saved trials
A Stepped Care Model of Adolescent Depression Treatment in Primary Care
A Stepped Care Model of Adolescent Depression Treatment in Primary Care
Status: Enrolling
Updated:  4/26/2013
New York State Psychiatric Institute
mi
from
New York, NY
A Stepped Care Model of Adolescent Depression Treatment in Primary Care
A Stepped Care Model of Adolescent Depression Treatment in Primary Care
Status: Enrolling
Updated: 4/26/2013
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
Status: Enrolling
Updated:  4/26/2013
New York State Psychiatric Institute
mi
from
New York, NY
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
Status: Enrolling
Updated: 4/26/2013
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
Status: Enrolling
Updated:  4/26/2013
New York-Presbyterian Hospital
mi
from
New York, NY
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
Status: Enrolling
Updated: 4/26/2013
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Aurora, CO
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Decatur, GA
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Baltimore, MD
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Boston, MA
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Rochester, MN
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Newark, NJ
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
New York, NY
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Cleveland, OH
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Versartis Trial in Children to Assess Long-Acting Growth Hormone
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials